tiprankstipranks
Avery Dennison Corp. (AVY)
NYSE:AVY

Avery Dennison (AVY) AI Stock Analysis

Compare
522 Followers

Top Page

AVAvery Dennison
(NYSE:AVY)
76Outperform
Avery Dennison scores a solid 76, reflecting its strong financial performance with consistent growth and profitability, combined with a positive earnings call outlook. The stock's technical indicators suggest a short-term bearish trend, though its valuation appears fair with a moderate P/E ratio and a small dividend yield. Despite some challenges noted in the earnings call, the company's strategic focus on high-value categories and partnerships positions it well for future growth.
Positive Factors
Financial Performance
AVY beat its initial top- and bottom-line 2024 guidance, delivering strong volume growth and impressive performance despite economic uncertainties.
Growth Potential
Despite the challenges, Avery's RFID/Intelligent Label business is seen as a significant long-term growth lever, with expected growth of 9-10%.
Negative Factors
Earnings
The share is trading at 12 months low as the 2024 earnings mix was unfavorable and earnings progression slowed through the year.

Avery Dennison (AVY) vs. S&P 500 (SPY)

Avery Dennison Business Overview & Revenue Model

Company DescriptionAvery Dennison Corp. engages in the provision of labeling and packaging materials and solutions. It operates through the following segments: Label & Graphic Materials, Retail Branding & Information Solutions and Industrial & Healthcare Materials. The Label and Graphic Materials Segment manufactures and sells Fasson, JAC, and Avery Dennison-brand pressure-sensitive label and packaging materials, Avery Dennison and Mactac brand graphics, and Avery Dennison brand reflective products. The Retail Branding and Information Solutions segment designs, manufactures, and sells a variety of branding and information solutions to retailers, brand owners, apparel manufacturers, distributors and industrial customers. The Industrial and Healthcare Materials Segment manufactures and sells Fasson-brand and Avery Dennison-brand tapes and fasteners, Vancive -brand medical pressure sensitive adhesive based materials and products, and performance polymers. The company was founded by R. Stanton Avery in 1935 and is headquartered in Glendale, CA.
How the Company Makes MoneyAvery Dennison makes money primarily through its two main business segments: Label and Graphic Materials (LGM) and Retail Branding and Information Solutions (RBIS). The LGM segment generates revenue by producing and selling pressure-sensitive label and packaging materials, which are used in various industries such as food, beverage, and pharmaceuticals. The RBIS segment contributes to the company's earnings by providing branding and information solutions, including tags, labels, and RFID inlays, which help improve inventory management and supply chain efficiency for retail businesses. Key partnerships with major consumer brands and retailers further enhance Avery Dennison's revenue streams, bolstered by the company's commitment to developing sustainable and innovative products.

Avery Dennison Financial Statement Overview

Summary
Avery Dennison displays strong financial health with consistent revenue growth, solid profitability margins, and effective cash flow management. The company's leverage is moderate, and while it has a strong return on equity, it needs to manage its debt levels prudently. Overall, Avery Dennison's financial statements indicate a well-positioned company in the industrial goods sector with healthy growth prospects.
Income Statement
85
Very Positive
Avery Dennison has demonstrated consistent revenue growth over the years with a notable increase from $8.36 billion in 2023 to $8.76 billion in 2024, marking a revenue growth rate of approximately 4.68%. The gross profit margin improved slightly to 28.90% in 2024. The net profit margin also increased to 8.05%, indicating effective cost management and operational efficiency. EBIT and EBITDA margins are strong at 12.82% and 15.79%, respectively, reflecting robust operational performance.
Balance Sheet
78
Positive
The debt-to-equity ratio stands at 1.36, indicating moderate leverage. However, the company's return on equity (ROE) improved to 30.39% in 2024, showcasing strong profitability relative to shareholder equity. The equity ratio is 27.58%, reflecting a balanced capital structure. While the company maintains adequate equity, it should be cautious of its debt levels.
Cash Flow
82
Very Positive
Avery Dennison achieved a healthy free cash flow growth rate of 34.91% from 2023 to 2024. The operating cash flow to net income ratio is robust at 1.33, indicating strong cash generation relative to net income. The free cash flow to net income ratio is also favorable at 1.04, demonstrating the company's capacity to generate cash beyond its accounting earnings.
Breakdown
Dec 2024Dec 2023Dec 2022Mar 2022Mar 2021
Income StatementTotal Revenue
8.76B8.36B9.04B8.41B6.97B
Gross Profit
2.53B2.28B2.40B2.31B1.92B
EBIT
1.12B963.80M1.08B1.06B856.70M
EBITDA
1.38B1.11B1.37B1.31B1.06B
Net Income Common Stockholders
704.90M503.00M757.10M740.10M555.90M
Balance SheetCash, Cash Equivalents and Short-Term Investments
329.10M250.10M167.20M162.70M252.30M
Total Assets
8.41B8.21B7.95B7.97B6.10B
Total Debt
3.15B3.24B3.10B3.10B2.12B
Net Debt
2.82B3.03B2.93B2.94B1.86B
Total Liabilities
6.09B6.08B5.92B6.05B4.60B
Stockholders Equity
2.32B2.13B2.03B1.92B1.50B
Cash FlowFree Cash Flow
730.00M540.90M662.50M774.70M532.70M
Operating Cash Flow
938.80M826.00M961.00M1.05B751.30M
Investing Cash Flow
-243.10M-459.00M-332.70M-1.74B-554.20M
Financing Cash Flow
-576.10M-317.20M-615.20M604.30M-207.70M

Avery Dennison Technical Analysis

Technical Analysis Sentiment
Negative
Last Price182.82
Price Trends
50DMA
186.54
Negative
100DMA
195.83
Negative
200DMA
206.59
Negative
Market Momentum
MACD
-0.71
Negative
RSI
41.61
Neutral
STOCH
49.15
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AVY, the sentiment is Negative. The current price of 182.82 is below the 20-day moving average (MA) of 183.41, below the 50-day MA of 186.54, and below the 200-day MA of 206.59, indicating a bearish trend. The MACD of -0.71 indicates Negative momentum. The RSI at 41.61 is Neutral, neither overbought nor oversold. The STOCH value of 49.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AVY.

Avery Dennison Risk Analysis

Avery Dennison disclosed 39 risk factors in its most recent earnings report. Avery Dennison reported the most risks in the “Legal & Regulatory” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Avery Dennison Peers Comparison

Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
AVAVY
76
Outperform
$14.32B20.7630.40%1.85%4.68%
IPIP
72
Outperform
$26.99B32.626.82%3.34%-1.57%84.85%
PKPKG
71
Outperform
$18.16B22.6418.28%2.39%7.45%5.43%
SOSON
68
Neutral
$4.55B28.027.22%4.50%-6.93%-65.66%
SESEE
67
Neutral
$4.52B16.8142.39%2.45%-1.75%-21.15%
60
Neutral
$13.01B10.450.79%3.53%1.60%-22.47%
OIOI
54
Neutral
$1.64B-42.06%-8.09%-1.97%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AVY
Avery Dennison
182.82
-27.58
-13.11%
IP
International Paper Co
52.51
18.12
52.69%
OI
O-I Glass
11.72
-4.48
-27.65%
PKG
Packaging
205.37
26.57
14.86%
SEE
Sealed Air
31.83
-2.94
-8.46%
SON
Sonoco Products
46.17
-8.13
-14.97%

Avery Dennison Earnings Call Summary

Earnings Call Date: Jan 30, 2025 | % Change Since: -4.77% | Next Earnings Date: Apr 23, 2025
Earnings Call Sentiment Positive
The earnings call conveyed a generally positive outlook with strong financial performance in 2024 and optimistic guidance for 2025. Key achievements included growth in Intelligent Labels and new partnerships with CVS Health and Kroger. However, there were challenges, such as softer than expected Vestcom sales and a decline in the logistics segment for Intelligent Labels.
Highlights
Strong Financial Performance in 2024
Sales grew 5%, adjusted EBITDA margin expanded by 130 basis points, and adjusted EPS grew 19% at the high end of original guidance.
Materials Group Growth
Delivered strong top-line growth in 2024 driven by significant volume growth and strong margin expansion. High-value categories and emerging markets were key catalysts.
Progress in Intelligent Labels
Enterprise-wide Intelligent Labels grew 9% on an organic basis in 2024, reaching roughly $900 million in revenue.
New Partnerships and Innovations
Signed a new partnership with CVS Health for Vestcom and announced a strategic collaboration with Kroger for Intelligent Labels.
Positive Outlook for 2025
Expect GDP-plus growth and expanding margins with adjusted EPS of $9.80 to $10.20, up 7% to 12%, excluding currency translation.
Lowlights
Vestcom Sales Below Expectations
Vestcom delivered softer than initially anticipated sales in 2024, primarily due to lower volume in the drugstore channel driven by store closures.
Logistics Segment Decline
Intelligent Labels sales in logistics were lower in 2024 due to the lack of a large RFID program rollout seen in 2023.
Raw Material Pricing Challenges
Year-over-year, some negative raw material pricing is expected to impact 2025, with a slight deflation in Q4 2024 and Q1 2025.
Company Guidance
In the recent earnings call, Avery Dennison provided robust guidance for 2025, projecting adjusted EPS growth of 7% to 12%, excluding currency impacts, with an expected range of $9.80 to $10.20. The company anticipates 3% to 4% organic sales growth, driven by mid-single-digit volume growth, with their high-value categories contributing significantly. Intelligent Labels are expected to grow 10% to 15%, adding 1 to 1.5 points to total company growth. The Materials Group is projected to achieve mid-single-digit volume growth, fueled by strong performance in high-value categories like specialty and durable labels. Furthermore, the Solutions Group is set to witness margin expansion, supported by new rollouts in high-value solutions such as Vestcom, which is expected to deliver strong growth following a new partnership with CVS Health. Overall, Avery Dennison is poised for continued margin expansion and top-quartile returns, bolstered by their strategic focus on high-value categories and disciplined capital allocation.

Avery Dennison Corporate Events

Executive/Board ChangesBusiness Operations and Strategy
Avery Dennison Appoints Danny Allouche as Interim CFO
Neutral
Nov 15, 2024

Avery Dennison Corporation has appointed Danny G. Allouche as Interim CFO following Gregory S. Lovins’ medical leave. Allouche, previously Senior VP and Chief Strategy Officer, will maintain his strategic role alongside his new financial responsibilities. Despite the interim nature of his appointment, his compensation package remains unchanged, highlighting the company’s strategic continuity amid leadership adjustments.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.